Company: IPAR
Filing Date: 2025-07-14
Form Type: PRE 14A
Source: 0001753926-25-001139
Chunk: 34

Company: INTERPARFUMS INC
Filing Date: 2025-07-14
Form: PRE 14A
Chunk 34
---
 as part of his long-term incentives. Unless the market price of our common stock increases, Mr. Atwood will have no tangible benefit from this option. Thus, the option holder is provided with the additional incentive to increase individual performance with the ultimate goal of increasing our overall performance. We believe that enhanced executive incentive that result in increased corporate performance tend to build company loyalty. No other stock option grants were made to other executive officers in 2024, 2023 or 2022, including Messrs. Jean Madar and Philippe Benacin. Interparfums SA Stock Compensation Plans 2024 - 2023 No shares were granted to any employees or corporate officers during either year. 2022 Free Share Plan – On March 16, 2022, the Board of Interparfums SA (“IPSA”) decided to grant 88,400 free shares of its capital stock to all of the IPSA’s employees and corporate officers having more than 6 months seniority at the grant date. The free shares are to be issued in June 2025. Issuance of those shares is based on satisfaction of performance conditions, relating to the 2024 IPSA sales for 50% of the shares and 2024 operating income for the balance.

|   | IPSA used the services of third party to assist them in the valuation of the plan, with the calculations and assumptions as follows: |
| ● | Management expects the rate of staff turnover to be 12%.                                                                             |

| ● | Using the Monte Carlo method, management expects the performance rate to be 80% on the IPSA and subsidiaries consolidated sales and 80.8% on the consolidated operating income. |

| ● | As of December 31, 2022 management has updated its expectation related to the performance rate to be 100% for both consolidated sales and consolidated operating income based on the above assumptions, the total expenses related to this plan are valued at $4.1 million. |

|   | As of December 31, 2023:                                                                                                     |
|:--|:-----------------------------------------------------------------------------------------------------------------------------|
| ● | 87,609 shares of IPSA Capital Stock, representing $4.1 million were purchased in the open market and allocated to this plan. |
|   | $1.4 million of expense was recorded (or $1.6 million including social contributions).                                       |

|   | As of December 31, 2024:                                                                                                     |
|:--|:-----------------------------------------------------------------------------------------------------------------------------|
| ●